RxSight Inc. (RXST)
NASDAQ (NMS) NASDAQ (NMS) Primary 
RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses.
RxSight: After Dropping To The Bottom, It's Time To Pick It Up
RxSight, Inc. exhibits quantitative similarities to other small caps that I have rated here on Seeking Alpha that strongly outperformed the market. RXST is an 'NCAV' opportunity, a company that sells for less than its current asset value even though management is putting the company back on the growth track. My thesis is grounded in historical patterns where cash-rich, loss-making small caps often resolve operational issues before exhausting reserves.
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
RxSight, Inc. (RXST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.03 per share a year ago.
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago.
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
